These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18419471)

  • 1. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.
    Spellberg B; Ibrahim AS; Lin L; Avanesian V; Fu Y; Lipke P; Otoo H; Ho T; Edwards JE
    J Infect Dis; 2008 Apr; 197(7):967-71. PubMed ID: 18419471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus.
    Spellberg B; Ibrahim AS; Yeaman MR; Lin L; Fu Y; Avanesian V; Bayer AS; Filler SG; Lipke P; Otoo H; Edwards JE
    Infect Immun; 2008 Oct; 76(10):4574-80. PubMed ID: 18644876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.
    Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B
    PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant.
    Lin L; Ibrahim AS; Avanesian V; Edwards JE; Fu Y; Baquir B; Taub R; Spellberg B
    Clin Vaccine Immunol; 2008 Mar; 15(3):582-4. PubMed ID: 18184821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein.
    Baquir B; Lin L; Ibrahim AS; Fu Y; Avanesian V; Tu A; Edwards J; Spellberg B
    J Infect Dis; 2010 Feb; 201(3):473-7. PubMed ID: 20039802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection.
    Wüthrich M; Dobson HE; Ledesma Taira C; Okaa UJ; Dos Santos Dias L; Isidoro-Ayza M; Petrovsky N; Klein BS
    mBio; 2021 Aug; 12(4):e0201821. PubMed ID: 34399628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
    Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
    Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
    Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
    J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response that protects against disseminated candidiasis.
    Han Y; Cutler JE
    Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
    Montagnoli C; Sandini S; Bacci A; Romani L; La Valle R
    Med Mycol; 2004 Aug; 42(4):319-24. PubMed ID: 15473356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
    Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
    Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
    Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
    Singh S; Uppuluri P; Mamouei Z; Alqarihi A; Elhassan H; French S; Lockhart SR; Chiller T; Edwards JE; Ibrahim AS
    PLoS Pathog; 2019 Aug; 15(8):e1007460. PubMed ID: 31381597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice.
    Portuondo DL; Batista-Duharte A; Ferreira LS; de Andrade CR; Quinello C; Téllez-Martínez D; de Aguiar Loesch ML; Carlos IZ
    Vaccine; 2017 Aug; 35(34):4430-4436. PubMed ID: 28687406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.